Adaptive Biotechnologies Corporation (ADPT)
NASDAQ · Healthcare
Adaptive Biotechnologies Corporation Cash on Hand 2017–2025
Adaptive Biotechnologies Corporation annual/quarterly cash on hand history from 2018 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Adaptive Biotechnologies Corporation cash on hand for the quarter ending December 31, 2025 were 70.5M, a 47.11% increase year-over-year.
- Adaptive Biotechnologies Corporation cash on hand for 2025 were 70.5M, a 47.11% increase from 2024.
- Adaptive Biotechnologies Corporation cash on hand for 2024 were 47.9M, a 26.35% decrease from 2023.
- Adaptive Biotechnologies Corporation cash on hand for 2023 were 65.1M, a 27.73% decrease from 2022.
- Adaptive Biotechnologies Corporation cash on hand for 2022 were 90.0M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Adaptive Biotechnologies Corporation Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $70 |
| 2024 | $48 |
| 2023 | $65 |
| 2022 | $90 |
| 2021 | $139 |
| 2020 | $123 |
| 2019 | $97 |
| 2018 | $55 |
| Adaptive Biotechnologies Corporation Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $70 |
| 2024-12-31 | $48 |
| 2023-12-31 | $65 |
| 2022-12-31 | $90 |
| 2021-12-31 | $139 |
| 2020-12-31 | $123 |
| 2019-12-31 | $97 |
| 2018-12-31 | $55 |
Adaptive Biotechnologies Corporation Cash on Hand — FAQ
Adaptive Biotechnologies Corporation (ADPT) cash on hand over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ADPT's cash on hand history?
The chart and table above show Adaptive Biotechnologies Corporation's cash on hand by year and by quarter, including the growth rate.